Erick Lucera
Insider Reports History
- Location
- North Andover, MA
- Signature
- /s/ Ron Caponigro, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Erick Lucera:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | Chief Financial Officer | Common Stock | 125,373 | $2,336,952 | $18.64 | 01 Apr 2026 | Direct |
| Editas Medicine, Inc. | EVP, CHIEF FINANCIAL OFFICER | Common Stock | 112,720 | $192,841 | $1.71 | 04 Mar 2025 | Direct |
| SAB Biotherapeutics, Inc. | Director | Stock option (right to buy) | 150,000 | 16 Dec 2025 | Direct | ||
| Dyne Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 105,000 | 12 Feb 2026 | Direct | ||
| Bone Biologics Corp | Director | Non-Employee Stock Option | 85,763 | 18 Sep 2023 | Direct | ||
| Editas Medicine, Inc. | EVP, CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 70,000 | 08 Mar 2025 | Direct | ||
| Beyond Air, Inc. | Director | Stock Options (Right to buy) | 3,750 | 04 Nov 2025 | Direct | ||
| AVEO PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | 19 Jan 2023 | Direct |
Insider Reports Filed by Erick Lucera
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 01 Apr 2026 | 1 | -$106,751 | 4 | Chief Financial Officer | 03 Apr 2026, 16:10 |
| DYN | Dyne Therapeutics, Inc. | 12 Feb 2026 | 2 | $0 | 4 | Chief Financial Officer | 17 Feb 2026, 17:08 |
| SABS | SAB Biotherapeutics, Inc. | 16 Dec 2025 | 1 | $0 | 4 | Director | 18 Dec 2025, 16:50 |
| XAIR | Beyond Air, Inc. | 04 Nov 2025 | 16 | $0 | 4 | Director | 06 Nov 2025, 21:51 |
| DYN | Dyne Therapeutics, Inc. | 31 Mar 2025 | 2 | $0 | 4 | Chief Financial Officer | 01 Apr 2025, 16:33 |
| DYN | Dyne Therapeutics, Inc. | 31 Mar 2025 | 0 | $0 | 3 | Chief Financial Officer | 01 Apr 2025, 16:31 |
| XAIR | Beyond Air, Inc. | 26 Mar 2025 | 1 | $0 | 4 | Director | 28 Mar 2025, 17:12 |
| EDIT | Editas Medicine, Inc. | 08 Mar 2025 | 2 | $0 | 4 | EVP, CHIEF FINANCIAL OFFICER | 27 Mar 2025, 16:41 |
| EDIT | Editas Medicine, Inc. | 04 Mar 2025 | 1 | -$7,030 | 4 | EVP, CHIEF FINANCIAL OFFICER | 05 Mar 2025, 16:44 |
| XAIR | Beyond Air, Inc. | 22 Nov 2024 | 14 | $0 | 4 | Director | 26 Nov 2024, 21:54 |
| XAIR | Beyond Air, Inc. | 14 Aug 2024 | 1 | +$15,565 | 4 | Director | 15 Aug 2024, 17:09 |
| SABS | SAB Biotherapeutics, Inc. | 15 Jul 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:30 |
| EDIT | Editas Medicine, Inc. | 20 May 2024 | 1 | -$125,404 | 4 | EVP, CHIEF FINANCIAL OFFICER | 22 May 2024, 16:30 |
| XAIR | Beyond Air, Inc. | 20 Mar 2024 | 1 | $0 | 4 | Director | 21 Mar 2024, 21:01 |
| EDIT | Editas Medicine, Inc. | 02 Mar 2024 | 3 | $0 | 4 | EVP, CHIEF FINANCIAL OFFICER | 05 Mar 2024, 20:06 |
| BBLG | Bone Biologics Corp | 18 Sep 2023 | 1 | $0 | 4 | Director | 20 Sep 2023, 14:54 |
| EDIT | Editas Medicine, Inc. | 17 May 2023 | 2 | $0 | 4 | EVP, CHIEF FINANCIAL OFFICER | 18 May 2023, 17:20 |
| EDIT | Editas Medicine, Inc. | 17 May 2023 | 0 | $0 | 3 | EVP, CHIEF FINANCIAL OFFICER | 18 May 2023, 17:18 |
| SABS | SAB Biotherapeutics, Inc. | 03 Apr 2023 | 1 | $0 | 4 | Director | 05 Apr 2023, 17:01 |
| SABS | SAB Biotherapeutics, Inc. | 03 Apr 2023 | 0 | $0 | 3 | Director | 05 Apr 2023, 17:00 |
| XAIR | Beyond Air, Inc. | 29 Mar 2023 | 1 | $0 | 4 | Director | 31 Mar 2023, 16:15 |
| XAIR | Beyond Air, Inc. | 16 Mar 2023 | 1 | +$13,634 | 4 | Director | 20 Mar 2023, 16:10 |
| /report/000089924323002182-lucera-erick-2023-01-19 | AVEO PHARMACEUTICALS, INC. | 19 Jan 2023 | 3 | $0 | 4 | Chief Financial Officer | 19 Jan 2023, 16:11 |
| BBLG | Bone Biologics Corp | 23 Aug 2022 | 1 | $0 | 4 | Director | 08 Mar 2023, 05:20 |
| XAIR | Beyond Air, Inc. | 03 Mar 2022 | 1 | $0 | 4 | Director | 07 Mar 2022, 07:33 |
| /report/000162828022003056-lucera-erick-2022-02-15 | AVEO PHARMACEUTICALS, INC. | 15 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 17 Feb 2022, 16:00 |
| BBLG | Bone Biologics Corp | 26 Oct 2021 | 2 | $0 | 4 | Director | 28 Feb 2022, 05:02 |
| BBLG | Bone Biologics Corp | 15 Oct 2021 | 0 | $0 | 3 | Director | 21 Oct 2021, 17:20 |